Happle Rudolf
Department of Dermatology, Medical Center-University of Freiburg, Freiburg, Germany.
Indian Dermatol Online J. 2021 Mar 2;12(2):316-318. doi: 10.4103/idoj.IDOJ_584_20. eCollection 2021 Mar-Apr.
Progressive osseous heteroplasia (POH) is a rarely occurring genetic condition characterized by severe segmental ossification involving the skin and deep connective tissues including the muscles. So far, the disorder is generally described as an autosomal dominant trait. By contrast, the following arguments are in favor of the alternative concept that POH should rather be taken as a non-specific segmental manifestation of different inactivation disorders such as Albright hereditary osteodystrophy (AHO) with hormone resistance, AHO without hormone resistance, and osteomatosis cutis. Presently, POH has got its own OMIM number 166350 but this is obviously wrong because the disorder does not reflect heterozygosity for a mutation. Conversely, the disorder is most likely due to an early event of postzygotic loss of heterozygosity with loss of the corresponding wild-type allele. This alternative concept, as proposed in 2016, offers a plausible explanation for the following features of POH. Familial occurrence is usually absent. POH is usually observed in families with one of the three inactivation disorders as mentioned above. Mosaicism is suggested by the pronounced segmental manifestation of POH and by its lateralization. Some patients have, in addition to POH, bilaterally disseminated features of osteomatosis cutis or AHO, and other patients have family members with one of these nonsegmental disorders. Remarkably, POH tends to appear much earlier than the nonsegmental inactivation disorders. - Molecular support of the concept was documented in a superficial variant of POH called 'plate-like osteoma cutis'. In several other autosomal dominant skin disorders, molecular corroboration of the theory of superimposed mosaicism has been provided. - For all of these reasons, it is unlikely that POH can further be taken as a distinct autosomal dominant trait. Generation of more molecular data in multiple cases of POH occurring in inactivation disorders will be crucial to corroborate the proposed concept.
进行性骨化性纤维发育不良(POH)是一种罕见的遗传性疾病,其特征是包括皮肤和深层结缔组织(包括肌肉)在内的严重节段性骨化。到目前为止,该疾病通常被描述为常染色体显性性状。相比之下,以下观点支持另一种概念,即POH更应被视为不同失活障碍的非特异性节段性表现,如伴有激素抵抗的奥尔布赖特遗传性骨营养不良(AHO)、不伴有激素抵抗的AHO以及皮肤骨瘤病。目前,POH有其自己的OMIM编号166350,但这显然是错误的,因为该疾病并不反映突变的杂合性。相反,该疾病很可能是由于合子后杂合性丧失的早期事件以及相应野生型等位基因的丢失所致。2016年提出的这一替代概念为POH的以下特征提供了合理的解释。通常不存在家族性发病情况。POH通常在患有上述三种失活障碍之一的家族中被观察到。POH明显的节段性表现及其偏侧化提示存在镶嵌现象。一些患者除了患有POH外,还具有双侧播散性的皮肤骨瘤病或AHO特征,而其他患者有患有这些非节段性疾病之一的家庭成员。值得注意的是,POH往往比非节段性失活障碍出现得早得多。——在一种称为“板状皮肤骨瘤”的POH浅表变体中记录了该概念的分子支持证据。在其他几种常染色体显性皮肤疾病中,也提供了叠加镶嵌理论的分子佐证。——基于所有这些原因,POH不太可能再被视为一种独特的常染色体显性性状。在失活障碍中发生的多例POH病例中生成更多分子数据对于证实所提出的概念至关重要。